• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黑色素瘤风险分层:在目的设计的前瞻性队列中得出和验证的模型。

Risk Stratification for Melanoma: Models Derived and Validated in a Purpose-Designed Prospective Cohort.

机构信息

Department of Population Health, QIMR Berghofer Medical Research Institute, Queensland, Australia.

School of Public Health, University of Queensland, Queensland, Australia.

出版信息

J Natl Cancer Inst. 2018 Oct 1;110(10):1075-1083. doi: 10.1093/jnci/djy023.

DOI:10.1093/jnci/djy023
PMID:29538697
Abstract

BACKGROUND

Risk stratification can improve the efficacy and cost-efficiency of screening programs for early detection of cancer. We sought to derive a risk stratification tool for melanoma that was suitable for the general population using only self-reported information.

METHODS

We used melanoma risk factor information collected at baseline from QSKIN, a prospective cohort study of Queensland adults age 40 to 69 years at recruitment (n = 41 954). We examined two separate outcomes: 1) invasive melanomas and 2) all melanomas (invasive + in situ) obtained through data linkage to the cancer registry. We used stepwise Cox proportional hazards modeling to derive the risk models in a randomly selected two-thirds sample of the data set and assessed model performance in the remaining one-third validation sample.

RESULTS

After a median follow-up of 3.4 years, 655 (1.6%) participants developed melanoma (257 invasive, 398 in situ). The prediction model for invasive melanoma included seven terms. At baseline, the strongest predictors of invasive melanoma were age, sex, tanning ability, number of moles at age 21 years, and number of skin lesions treated destructively. The model for "all melanomas" (ie, invasive and in situ) included five additional terms. Discrimination in the validation data set was high for both models (C-index = 0.69, 95% confidence interval [CI] = 0.62 to 0.76, and C-index = 0.72, 95% CI = 0.69 to 0.75, respectively), and calibration was acceptable.

CONCLUSIONS

Such a tool could be used to target surveillance activities to those at highest predicted risk of developing melanoma over a median duration of 3.4 years.

摘要

背景

风险分层可以提高癌症早期检测筛查计划的效果和成本效益。我们试图仅使用自我报告信息为普通人群开发一种适用于黑色素瘤的风险分层工具。

方法

我们使用 QSKIN 前瞻性队列研究中在基线时收集的黑色素瘤危险因素信息,该研究纳入了昆士兰州招募时年龄在 40 至 69 岁的成年人(n = 41954)。我们检查了两个独立的结果:1)侵袭性黑色素瘤和 2)通过与癌症登记处的数据链接获得的所有黑色素瘤(侵袭性+原位)。我们使用逐步 Cox 比例风险建模在数据集的三分之二随机选择的样本中推导风险模型,并在剩余的三分之一验证样本中评估模型性能。

结果

中位随访 3.4 年后,655 名(1.6%)参与者发生了黑色素瘤(257 例侵袭性,398 例原位)。侵袭性黑色素瘤预测模型包括七个术语。在基线时,侵袭性黑色素瘤最强的预测因素是年龄、性别、晒黑能力、21 岁时的痣数和破坏性治疗的皮肤病变数。“所有黑色素瘤”(即侵袭性和原位)模型包括另外五个术语。两个模型在验证数据集中的区分度都很高(C 指数=0.69,95%置信区间[CI]为 0.62 至 0.76,和 C 指数=0.72,95%CI 为 0.69 至 0.75),校准效果也可以接受。

结论

这种工具可以用于针对那些在中位 3.4 年时间内黑色素瘤发生风险最高的人进行监测活动。

相似文献

1
Risk Stratification for Melanoma: Models Derived and Validated in a Purpose-Designed Prospective Cohort.黑色素瘤风险分层:在目的设计的前瞻性队列中得出和验证的模型。
J Natl Cancer Inst. 2018 Oct 1;110(10):1075-1083. doi: 10.1093/jnci/djy023.
2
Smoking and Cutaneous Melanoma: Findings from the QSkin Sun and Health Cohort Study.吸烟与皮肤黑色素瘤:来自 QSkin 阳光与健康队列研究的结果。
Cancer Epidemiol Biomarkers Prev. 2018 Aug;27(8):874-881. doi: 10.1158/1055-9965.EPI-17-1056. Epub 2018 May 22.
3
A risk prediction model for the development of subsequent primary melanoma in a population-based cohort.基于人群的队列中继发原发性黑色素瘤发展的风险预测模型。
Br J Dermatol. 2020 May;182(5):1148-1157. doi: 10.1111/bjd.18524. Epub 2019 Nov 27.
4
Risk of Next Melanoma in Patients With Familial and Sporadic Melanoma by Number of Previous Melanomas.根据既往黑色素瘤数量评估家族性和散发性黑色素瘤患者的下一个黑色素瘤风险。
JAMA Dermatol. 2015 Jun;151(6):607-15. doi: 10.1001/jamadermatol.2014.4777.
5
Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002.1982 - 2002年澳大利亚昆士兰州原位和侵袭性黑色素瘤的发病趋势。
Cancer Causes Control. 2006 Feb;17(1):21-7. doi: 10.1007/s10552-005-3637-4.
6
Risk of second primary in situ and invasive melanoma in a Dutch population-based cohort: 1989-2008.荷兰基于人群队列的研究:1989-2008 年原位和侵袭性黑色素瘤的二次原发性发病风险。
Br J Dermatol. 2012 Dec;167(6):1321-30. doi: 10.1111/j.1365-2133.2012.11123.x.
7
Risk of subsequent melanoma after melanoma in situ and invasive melanoma: a population-based study from 1973 to 2011.原位黑色素瘤和侵袭性黑色素瘤后黑色素瘤的风险:1973 年至 2011 年的一项基于人群的研究。
J Am Acad Dermatol. 2015 May;72(5):794-800. doi: 10.1016/j.jaad.2015.02.006. Epub 2015 Mar 11.
8
Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden.类风湿关节炎、肿瘤坏死因子拮抗剂治疗与恶性黑色素瘤风险:来自瑞典的全国基于人群的前瞻性队列研究。
BMJ. 2013 Apr 8;346:f1939. doi: 10.1136/bmj.f1939.
9
Trends in the diagnosis and clinical features of melanoma in situ (MIS) in US men and women: A prospective, observational study.美国男性和女性原位黑色素瘤(MIS)的诊断趋势及临床特征:一项前瞻性观察研究。
J Am Acad Dermatol. 2016 Oct;75(4):698-705. doi: 10.1016/j.jaad.2016.05.011. Epub 2016 Jul 16.
10
Association of Patient Risk Factors and Frequency of Nevus-Associated Cutaneous Melanomas.患者风险因素与痣相关皮肤黑色素瘤发生频率的相关性。
JAMA Dermatol. 2016 Mar;152(3):291-8. doi: 10.1001/jamadermatol.2015.3775.

引用本文的文献

1
Melanoma Skin Cancer: A Comprehensive Review of Current Knowledge.黑色素瘤皮肤癌:当前知识的全面综述
Cancers (Basel). 2025 Sep 5;17(17):2920. doi: 10.3390/cancers17172920.
2
A Risk Prediction Tool for Invasive Melanoma.一种侵袭性黑色素瘤的风险预测工具。
JAMA Dermatol. 2025 Sep 10. doi: 10.1001/jamadermatol.2025.3028.
3
Risk Factors for Incident Nevus-Associated vs De Novo Invasive Melanoma.痣相关侵袭性黑色素瘤与新发侵袭性黑色素瘤的发病风险因素。
JAMA Dermatol. 2025 Jul 9. doi: 10.1001/jamadermatol.2025.2004.
4
A multimodal vision foundation model for clinical dermatology.一种用于临床皮肤科的多模态视觉基础模型。
Nat Med. 2025 Jun 6. doi: 10.1038/s41591-025-03747-y.
5
Artificial intelligence and skin cancer.人工智能与皮肤癌
Front Med (Lausanne). 2024 Mar 19;11:1331895. doi: 10.3389/fmed.2024.1331895. eCollection 2024.
6
Predicting skin cancer risk from facial images with an explainable artificial intelligence (XAI) based approach: a proof-of-concept study.基于可解释人工智能(XAI)方法从面部图像预测皮肤癌风险:一项概念验证研究。
EClinicalMedicine. 2024 Mar 19;71:102550. doi: 10.1016/j.eclinm.2024.102550. eCollection 2024 May.
7
Acceptability and appropriateness of a risk-tailored organised melanoma screening program: Qualitative interviews with key informants.风险定制化的有组织黑色素瘤筛查项目的可接受性和适宜性:关键信息提供者的定性访谈。
PLoS One. 2023 Dec 13;18(12):e0287591. doi: 10.1371/journal.pone.0287591. eCollection 2023.
8
ACEMID cohort study: protocol of a prospective cohort study using 3D total body photography for melanoma imaging and diagnosis.ACEMID 队列研究:一项使用 3D 全身摄影进行黑色素瘤成像和诊断的前瞻性队列研究方案。
BMJ Open. 2023 Sep 28;13(9):e072788. doi: 10.1136/bmjopen-2023-072788.
9
The diagnosis and initial management of melanoma in Australia: findings from the prospective, population-based QSkin study.澳大利亚黑色素瘤的诊断和初步管理:来自前瞻性、基于人群的 QSkin 研究的结果。
Med J Aust. 2023 May 15;218(9):402-407. doi: 10.5694/mja2.51919. Epub 2023 Apr 11.
10
Inter-Rater Agreement in Assessing Risk of Bias in Melanoma Prediction Studies Using the Prediction Model Risk of Bias Assessment Tool (PROBAST): Results from a Controlled Experiment on the Effect of Specific Rater Training.使用预测模型偏倚风险评估工具(PROBAST)评估黑色素瘤预测研究中偏倚风险的评分者间一致性:关于特定评分者培训效果的对照实验结果
J Clin Med. 2023 Mar 2;12(5):1976. doi: 10.3390/jcm12051976.